Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W J Ferguson

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Neuroreport|September 5, 2006
Scarring impedes regeneration at sites of peripheral nerve repairSimon Atkins, Keith G Smith, Alison R Loescher, et al.
The Journal of Bone and Joint Surgery. British Volume|April 2, 2002
Genetic susceptibility in Dupuytren's disease. TGF-beta1 polymorphisms and Dupuytren's diseaseA Bayat, J S Watson, J K Stanley, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|July 29, 2011
Discovery and development of avotermin (recombinant human transforming growth factor beta 3): a new class of prophylactic therapeutic for the improvement of scarringNick L Occleston, Sharon O'Kane, Hugh G Laverty, et al.
International Journal of Epidemiology|December 1, 1990
Oral contraceptive oestrogen and progestin potencies and the incidence of deep venous thromboembolismB B Gerstman, J M Piper, J P Freiman, et al.
Plastic and Reconstructive Surgery|November 3, 2010
Scar-improving efficacy of avotermin administered into the wound margins of skin incisions as evaluated by a randomized, double-blind, placebo-controlled, phase II clinical trialJames Bush, Jonathan A L Duncan, Jeremy S Bond, et al.
Developmental Biology|October 12, 2002
TGF-beta(3)-induced chondroitin sulphate proteoglycan mediates palatal shelf adhesionA Gato, M L Martinez, C Tudela, et al.
Plastic and Reconstructive Surgery|December 29, 2004
Identification of a novel mitochondrial mutation in Dupuytren's disease using multiplex DHPLCArdeshir Bayat, Joanne Walter, Helen Lambe, et al.
The British Journal of Surgery|May 28, 2011
Randomized phase II clinical trial of avotermin versus placebo for scar improvementP T McCollum, J A Bush, G James, et al.
Journal of the Peripheral Nervous System : JPNS|November 29, 2007
Interleukin-10 reduces scarring and enhances regeneration at a site of sciatic nerve repairSimon Atkins, Alison R Loescher, Fiona M Boissonade, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|July 29, 2011
Recommendations on clinical proof of efficacy for potential scar prevention and reduction therapiesJames A Bush, D Angus McGrouther, V Leroy Young, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Neuroreport|September 5, 2006
Scarring impedes regeneration at sites of peripheral nerve repairSimon Atkins, Keith G Smith, Alison R Loescher, et al.
The Journal of Bone and Joint Surgery. British Volume|April 2, 2002
Genetic susceptibility in Dupuytren's disease. TGF-beta1 polymorphisms and Dupuytren's diseaseA Bayat, J S Watson, J K Stanley, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|July 29, 2011
Discovery and development of avotermin (recombinant human transforming growth factor beta 3): a new class of prophylactic therapeutic for the improvement of scarringNick L Occleston, Sharon O'Kane, Hugh G Laverty, et al.
International Journal of Epidemiology|December 1, 1990
Oral contraceptive oestrogen and progestin potencies and the incidence of deep venous thromboembolismB B Gerstman, J M Piper, J P Freiman, et al.
Plastic and Reconstructive Surgery|November 3, 2010
Scar-improving efficacy of avotermin administered into the wound margins of skin incisions as evaluated by a randomized, double-blind, placebo-controlled, phase II clinical trialJames Bush, Jonathan A L Duncan, Jeremy S Bond, et al.
Developmental Biology|October 12, 2002
TGF-beta(3)-induced chondroitin sulphate proteoglycan mediates palatal shelf adhesionA Gato, M L Martinez, C Tudela, et al.
Plastic and Reconstructive Surgery|December 29, 2004
Identification of a novel mitochondrial mutation in Dupuytren's disease using multiplex DHPLCArdeshir Bayat, Joanne Walter, Helen Lambe, et al.
The British Journal of Surgery|May 28, 2011
Randomized phase II clinical trial of avotermin versus placebo for scar improvementP T McCollum, J A Bush, G James, et al.
Journal of the Peripheral Nervous System : JPNS|November 29, 2007
Interleukin-10 reduces scarring and enhances regeneration at a site of sciatic nerve repairSimon Atkins, Alison R Loescher, Fiona M Boissonade, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|July 29, 2011
Recommendations on clinical proof of efficacy for potential scar prevention and reduction therapiesJames A Bush, D Angus McGrouther, V Leroy Young, et al.
Pageof 10